Bios Biotech

Hubei Bios Biotech Co., Ltd. was established in 2011 and is a high-tech enterprise focused on providing professional services for life science research. Over the past 13 years, it has been deeply engaged in research-oriented medical pathology technical services, molecular biology experimental technical services, cell experiment technical services, protein and biochemical testing services, animal model pathology evaluation and analysis, as well as scientific research and diagnostic reagent development, committed to providing customers with competitive life and health research solutions and helping customers improve R&D efficiency.
The company headquarters is located in Jianghan District, Wuhan City, Hubei Province, and has established branches in major biomedical research hubs across China, including Beijing, Tianjin, Shanghai, Guangzhou, Hangzhou, Nanjing, Wuhan, Changsha, Chengdu, and Chongqing.
The headquarters R&D center covers an area of approximately 4,000 square meters, with more than 200 sets of experimental instruments and facilities. It has been granted 19 intellectual property achievements, including 8 newly built digital and networked professional management systems, 2 invention patents, and 9 utility model patents. It has successively won many honors such as "High-tech Enterprise," "Wuhan Science and Technology Little Giant Enterprise," "Innovative Small and Medium-sized Enterprise," "Innovation Practice Base of Tongji Medical College Alumni Association of Huazhong University of Science and Technology," and "Graduate Innovation Practice Base of Wuhan University of Science and Technology Medical College."
The company currently has more than 140 formal employees, including more than 70 professional and technical personnel. The core technical team is led by pathology experts with more than 10 years of film-reading experience and senior pathologists, and brings together outstanding graduates in biology and medicine from well-known domestic universities, outstanding talents with overseas study backgrounds, and professional technical personnel and sales engineers deeply engaged in scientific research pathology. The research-oriented pathology volume of its life science service team has exceeded that of general super-large Grade 3A hospitals, reaching more than 15 million slides, and has cumulatively served more than 250,000 medical researchers and more than 110 pharmaceutical R&D companies.
The company has always adhered to customer-oriented principles, focused on customer concerns, and taken seeking truth from facts and utmost integrity and trustworthiness as its code of conduct. It is committed to providing competitive health research solutions and services and achieving customer success! Create newer and better technologies and services for the world, and create optimal efficiency for health research at better costs! It forges ahead with the vision of becoming an excellent health technology service enterprise.